PDUFA VI: NORD Wants Reviewers To Be More Accessible
As rare disease experts become part of orphan drug reviews, stakeholder group says they also should be more accessible to the public.
You may also be interested in...
Patient Engagement Collaborative expected to invite stakeholders to discuss how patient interaction with FDA can improve.
FDA floats idea of central office to coordinate patient engagement for symbolic as well as practical reasons.
Agency is still working to get oncology center of excellence off the ground and has other large pending reorganizations that could take precedence.